Cargando…
Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606454/ https://www.ncbi.nlm.nih.gov/pubmed/33298884 http://dx.doi.org/10.1038/s41421-020-00202-9 |
_version_ | 1783604484856872960 |
---|---|
author | Gao, Han Cai, Haiyan Liu, Jia Wang, Xiaoxiao Zheng, Pan Devenport, Martin Xu, Ting Dou, Fei Liu, Yang Zhou, Aiwu |
author_facet | Gao, Han Cai, Haiyan Liu, Jia Wang, Xiaoxiao Zheng, Pan Devenport, Martin Xu, Ting Dou, Fei Liu, Yang Zhou, Aiwu |
author_sort | Gao, Han |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7606454 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-76064542020-11-04 Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody Gao, Han Cai, Haiyan Liu, Jia Wang, Xiaoxiao Zheng, Pan Devenport, Martin Xu, Ting Dou, Fei Liu, Yang Zhou, Aiwu Cell Discov Correspondence Springer Singapore 2020-11-03 /pmc/articles/PMC7606454/ /pubmed/33298884 http://dx.doi.org/10.1038/s41421-020-00202-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Correspondence Gao, Han Cai, Haiyan Liu, Jia Wang, Xiaoxiao Zheng, Pan Devenport, Martin Xu, Ting Dou, Fei Liu, Yang Zhou, Aiwu Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody |
title | Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody |
title_full | Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody |
title_fullStr | Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody |
title_full_unstemmed | Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody |
title_short | Structure of CTLA-4 complexed with a pH-sensitive cancer immunotherapeutic antibody |
title_sort | structure of ctla-4 complexed with a ph-sensitive cancer immunotherapeutic antibody |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606454/ https://www.ncbi.nlm.nih.gov/pubmed/33298884 http://dx.doi.org/10.1038/s41421-020-00202-9 |
work_keys_str_mv | AT gaohan structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody AT caihaiyan structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody AT liujia structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody AT wangxiaoxiao structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody AT zhengpan structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody AT devenportmartin structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody AT xuting structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody AT doufei structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody AT liuyang structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody AT zhouaiwu structureofctla4complexedwithaphsensitivecancerimmunotherapeuticantibody |